Prostate Cancer and You is a monthly podcast presented by the Massachusetts Prostate Cancer Coalition that explores all aspects of the disease and will feature discussions with newsmakers and leaders from the world of prostate cancer research, caregivers, and patients. This important dialog is offered as a way to help educate, connect, and support men-at-risk, newly diagnosed individuals, survivors, and their families. It also serves to connect organizations and professionals worldwide that seek to conquer and cure prostate cancer. To learn more about the MPCC and to hear the podcast, go to masspcc.org. You can also listen on Apple Podcasts, Google Podcasts, Stitcher, Tunein and with all Android players.
All content for Prostate Cancer and You is the property of Mass Prostate Cancer Coalition and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Prostate Cancer and You is a monthly podcast presented by the Massachusetts Prostate Cancer Coalition that explores all aspects of the disease and will feature discussions with newsmakers and leaders from the world of prostate cancer research, caregivers, and patients. This important dialog is offered as a way to help educate, connect, and support men-at-risk, newly diagnosed individuals, survivors, and their families. It also serves to connect organizations and professionals worldwide that seek to conquer and cure prostate cancer. To learn more about the MPCC and to hear the podcast, go to masspcc.org. You can also listen on Apple Podcasts, Google Podcasts, Stitcher, Tunein and with all Android players.
Today’s “Prostate Cancer and You” podcast features Dr. Adam Kibel is chair of the department of urology at Mass General Brigham. In this conversation with host Jordan Rich, Dr. Kibel discusses a clinical trial focused on using genetic data and MRI to improve early detection of prostate cancer. The trial, involving men aged 40-69, aims to identify high-risk individuals through genetic testing and targeted screening. Dr. Kibel discusses the importance of clinical trials as well as the promise of this particular study to improve detection, treatment, and even prevention of prostate cancer in the future.
You can learn more about the study at https://rally.massgeneralbrigham.org/study/prostate_polygenic_risk_score.
Dr. Adam S. Kibel is chair of urology at Mass General Brigham. In addition, he is the Elliott Carr Cutler Professor of Surgery at Harvard Medical Medicine and chairman of the Harvard Urology Residency Program. Dr. Kibel received his undergraduate and medical degrees from Cornell University, completed his urology residency at the Harvard Urology Program, and completed his fellowship at the Brady Urologic Institute at Johns Hopkins.
Prostate Cancer and You
Prostate Cancer and You is a monthly podcast presented by the Massachusetts Prostate Cancer Coalition that explores all aspects of the disease and will feature discussions with newsmakers and leaders from the world of prostate cancer research, caregivers, and patients. This important dialog is offered as a way to help educate, connect, and support men-at-risk, newly diagnosed individuals, survivors, and their families. It also serves to connect organizations and professionals worldwide that seek to conquer and cure prostate cancer. To learn more about the MPCC and to hear the podcast, go to masspcc.org. You can also listen on Apple Podcasts, Google Podcasts, Stitcher, Tunein and with all Android players.
